H.R. 919 (119th)Bill Overview

Chronic Disease Flexible Coverage Act

Taxation|Health care costs and insuranceHealth care coverage and access
Cosponsors
Support
Republican
Introduced
Feb 4, 2025
Discussions
Bill Text
Current stageCommittee

Received in the Senate and Read twice and referred to the Committee on Finance.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

<p><strong>Chronic Disease Flexible Coverage Act</strong></p><p>This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible&nbsp;or with a deductible below the minimum threshold.</p><p>Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold.&nbsp;</p><p>The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include</p><ul><li>angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;</li><li>anti-resorptive therapy for individuals with osteoporosis or&nbsp;osteopenia;</li><li>beta-blockers for individuals with congestive heart failure or coronary artery disease;</li><li>blood pressure monitors for individuals with hypertension;</li><li>inhaled&nbsp;corticosteroids and peak flow meters for individuals with asthma;</li><li>insulin and other glucose lowering agents, retinopathy screening,&nbsp;glucometers, and hemoglobin A1c testing for individuals with diabetes;</li><li>international normalized ratio testing for individuals with liver disease or bleeding disorders;</li><li>low-density lipoprotein testing for individuals with heart disease;</li><li>statins for individuals with heart disease or diabetes; and</li><li>selective&nbsp;serotonin reuptake inhibitors for individuals with depression.&nbsp;</li></ul><p>The bill provides statutory authority for the IRS's guidance.&nbsp;</p>

Why people may split

The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.

Watch point

The next hurdle is reproducing that support in the other chamber.

<p><strong>Chronic Disease Flexible Coverage Act</strong></p><p>This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible&nbsp;or with a deductible below the minimum threshold.</p><p>Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually.

However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold.&nbsp;</p><p>The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include</p><ul><li>angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;</li><li>anti-resorptive therapy for individuals with osteoporosis or&nbsp;osteopenia;</li><li>beta-blockers for individuals with congestive heart failure or coronary artery disease;</li><li>blood pressure monitors for individuals with hypertension;</li><li>inhaled&nbsp;corticosteroids and peak flow meters for individuals with asthma;</li><li>insulin and other glucose lowering agents, retinopathy screening,&nbsp;glucometers, and hemoglobin A1c testing for individuals with diabetes;</li><li>international normalized ratio testing for individuals with liver disease or bleeding disorders;</li><li>low-density lipoprotein testing for individuals with heart disease;</li><li>statins for individuals with heart disease or diabetes; and</li><li>selective&nbsp;serotonin reuptake inhibitors for individuals with depression.&nbsp;</li></ul><p>The bill provides statutory authority for the IRS's guidance.&nbsp;</p>

Passage64/100

This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.

CredibilityPartial

How solid the drafting looks.

Contention62/100

The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens0% / 100%
Likely helpedLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • No clear beneficiaries surfaced yet.
Likely burdened
  • No clear downsides surfaced yet.
03 · Why people split

Why the argument around this bill splits.

The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
Progressive

The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.

Unclear
Centrist

The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.

Unclear
Conservative

The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.

Unclear
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood64/100

This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.

Why this could stall
  • The next hurdle is reproducing that support in the other chamber.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.

This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.

Unlocked analysis

Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Chronic Disease Flexible Coverage Act.

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis